Hao Ling

机构：Meizhou City People's Hospital, Meizu (China) · ORCID：0000-0001-6266-7159

发表论文 9 篇 · 总被引 292 次 · h-index 5

代表论文

• Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era (2022 · Acta Pharmaceutica Sinica B · 被引 148)
• Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency (2020 · Acta Pharmaceutica Sinica B · 被引 45)
• Both‐In‐One Hybrid Bacteria Suppress the Tumor Metastasis and Relapse via Tandem‐Amplifying Reactive Oxygen Species‐Immunity Responses (2021 · Advanced Healthcare Materials · 被引 39)
• Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease (2022 · Chinese Chemical Letters · 被引 34)
• Soil Respiration, Nitrification, and Denitrification in a Wheat Farmland Soil under Different Managements (2013 · Communications in Soil Science and Plant Analysis · 被引 20)
• Increase of antibiotic resistance genes via horizontal transfer in single- and two-chamber microbial electrolysis cells (2022 · Environmental Science and Pollution Research · 被引 4)